Dr. Martens PLC AGM Trading Update
11 July 2024 - 4:00PM
RNS Regulatory News
RNS Number : 9383V
Dr. Martens PLC
11 July 2024
11 July 2024
Dr. Martens plc - AGM Trading
Update
Today, Dr. Martens plc will hold its
annual general meeting at 09.30 at the Holiday Inn London, Camden
Lock, 30 Jamestown Road, London.
Trading since the start of this
financial year has been in line with expectations and our guidance
for FY25 remains unchanged. As always, Q1 is the smallest period of
our financial year, representing the end of the Spring/Summer
season. As communicated in our recent FY24 results, the current
financial year will be very second-half weighted, particularly from
a profit perspective.
The upcoming Autumn/Winter 24 season
remains a key focus and detailed trading plans, as discussed in our
recent FY24 results, are being implemented. We continue to target
positive DTC growth in the USA in H2. Work on our cost action plan
is ongoing and we will provide a detailed update at our first half
results in November.
Enquiries
Investors and analysts
Bethany Barnes, Director of Investor
Relations
+44 7825 187465
bethany.barnes@drmartens.com
Beth Callum, Investor Relations
Manager
beth.callum@drmartens.com
Press
Gill Hammond, Director of
Communications
+44 7384 214248
H/Advisors Maitland
+44 20 7379
5151
Katharine Spence
+44
7384 535739
About Dr. Martens
Dr. Martens is an iconic British
brand founded in 1960 in Northamptonshire. Originally produced for
workers looking for tough, durable boots, the brand was quickly
adopted by diverse youth subcultures and associated musical
movements. Dr. Martens has since transcended its working-class
roots while still celebrating its proud heritage and, six decades
later, "Docs" or "DMs" are worn by people around the world who use
them as a symbol of empowerment and their own individual
attitude.
The Company listed successfully on
the main market of the London Stock Exchange on 29 January 2021
(DOCS.L) and is a constituent of the FTSE 250 index.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
TSTSFDFMSELSEDW
Dr. Martens (LSE:DOCS)
Historical Stock Chart
From Nov 2024 to Dec 2024
Dr. Martens (LSE:DOCS)
Historical Stock Chart
From Dec 2023 to Dec 2024
